C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molec
客服专线︰ +852 3018 4526
交易日︰全日24小时 | 非交易日：9:00-18:00
